Human papillomavirus (HPV) is the most common sexually transmitted pathogen in the 25 United States, causing 99% of cervical cancers and 5% of all human cancers worldwide. 26 HPV infection requires transport of the viral genome (vDNA) into the nucleus of basal 27 keratinocytes. During this process, minor capsid protein L2 facilitates subcellular 28 retrograde trafficking of the vDNA from endosomes to the Golgi, and accumulation at 29 host chromosomes during mitosis for nuclear retention and localization during 30 interphase. Here we investigated the relationship between cytosolic GSH and HPV16 31 infection. siRNA knockdown of GSH biosynthetic enzymes results in a partial decrease 32 of HPV16 infection. Likewise, infection of HPV16 in GSH depleted keratinocytes is 33 inefficient, an effect that was not seen with adenoviral vectors. Analysis of trafficking 34 revealed no defects in cellular binding, entry, furin cleavage of L2, or retrograde 35 trafficking of HPV16, but GSH depletion hindered post-Golgi trafficking and 36 translocation, decreasing nuclear accumulation of vDNA. Although precise mechanisms 37
Introduction 41
Human papillomavirus (HPV) is the most common sexually transmitted infection 7 levels of GSH to be observed. After 72h treatment with 800µM BSO, cytosolic GSH 138 levels were drastically depleted compared to the control vehicle-treated cells (Table 1) . 139 BSO treated HaCaT cells displayed a slightly slower proliferation rate and cell cycle 140 anaylsis by PI staining revealed a subtle but statistically insignificant expansion of S 141 phase upon BSO treatment (Fig 2A,B) . This is consistent with other studies that BSO 142 treatment does not considerably alter cell cycle kinetics (47, 48) . HPV16 infection levels 143 dropped about 70% upon BSO treatment ( Fig 2C) , again suggesting that cytosolic GSH 144 is required for efficient HPV16 infection. To rule out pleiotropic effects of BSO on 145 luciferase expression, control or BSO treated HaCaT cells were infected with a 146 luciferase-expressing ∆E1/E3 adenovirus (HAd5-Luc) and luciferase was measured 24h 147 post infection. In this case, BSO actually enhanced HAd5-luc infection (Fig 2D) , 148 implying that the inhibition of HPV16 is not due to some non-specific effects of BSO on 149 cellular viability, endocytosis, general transcription, or activity of the luciferase enzyme 150 itself.
152
Effects of GSH depletion on viral binding, entry, and uncoating. 153 To determine the reason for inefficient HPV16 infection upon GSH depletion we 154 performed binding and entry studies. We first investigated HPV16 binding to control or 155 BSO treated HaCaT cells. Pre-chilled cells were infected with HPV16 for 1h at 4°C to 156 prevent viral endocytosis (49) and unbound virus was extensively washed away. Some 157 groups received an additional wash in PBS buffer at pH=10.75 to remove any cell-158 bound virus as previously reported (12) . Cell lysates were then collected, and bound L1 159 was detected by non-reducing SDS-PAGE and western blot. Similar levels of full-length 160 8 disulfide-linked L1 dimers and trimers were observed in control or BSO treated samples 161 that did not receive the high pH washes ( Fig 3A,B) , indicating that GSH depletion had 162 no effect on HPV16 binding and the the high pH wash does indeed remove extracellular 163 virus. 164 Next we investigated viral uptake by pre-binding HPV16 to cells followed by a 2h 165 shift to 37°C to allow entry. After 2h cells were either processed for non-reducing L1 166 western blot or cleared of extracellular virus by high pH washing and returned to 37C for 167 additional times. In this manner we are able to track the population of intracellular 168 HPV16 that has entered the cells during the initial 2h incubation. Upon return to 37°C 169 this "2h wave" of incoming virus will continue trafficking through the degradative in this manner revealed no major differences between control and BSO treated HaCaT 173 cells ( Fig 3C) . Both groups accumulated similar levels of high molecular weight (HMW) 174 L1 within the initial 2h of uptake, and both groups showed similar kinetics of L1 175 degradation as evidenced by disappearance of the HMW L1 and concomitant 176 appearance of the smaller 25 kDa L1 cleavage product.
177
Additional immunofluorescence and microscopy experiments were performed to 178 investigate viral trafficking and disassembly within control and BSO treated cells. After 179 HPV16 uptake, resident proteases within the acidic endosomal compartments promote 180 the breakdown and disassembly of the L1 capsid. Although this degradative uncoating 181 is not an obligate step of the infectious trafficking pathway, it does serve as a proxy for 182 endolysosomal trafficking (8, 50, 51) . Exposure of the L1-7 epitope, which is buried within 183 the intact capsid (52), is a useful marker for degradative uncoating and normally occurs 184 by 6-8h post infection (53). Control and BSO treated cells were infected with HPV16 for 185 2h or 8h and total L1 or L1-7 levels were visualized by immunofluorescence staining 186 and confocal microscopy. L1-7 was undetectable in either group at the early 2h time 187 point, as expected ( Fig 3D) . Both the control and BSO treated groups displayed 188 significant L1-7 signal by 8h, indicative of capsid degradation and proper endolysosomal 189 trafficking ( Fig 3D) . Taken together these data suggest GSH depletion does not 190 significantly affect HPV16 binding, entry, or early subcellular trafficking events. No significant differences were observed in the amount of cleaved L2 ( Fig 3E) , 203 indicating that cytosolic GSH does not affect furin processing of L2. p230 was used as the counterstain for the trans-Golgi. Nuclei were stained with DAPI.
218
In control cells most of the EdU-labeled vDNA or L2-3xFlag was found overlapping with 219 DAPI, within the cell nucleus ( Fig 4A,B ,C). In contrast, BSO treatment resulted in the 220 retention of the vast majority of EdU labeled vDNA or L2-3xFlag within the trans-Golgi, 221 as seen by overlap with either TGN46 or p230 ( Fig 4A,B ,C). Manders overlap 222 coefficients (56) were measured from multiple Z-stacks across replicate experiments 223 and differences were found to be statistically significant ( Fig 4D) . These data indicate 224 that while L2/vDNA was efficiently transported to the trans-Golgi, GSH depletion 225 prevented efficient exit from this compartment.
226
In prior work we developed a system to monitor translocation of L2 across 227 limiting membranes (23). The platform is based on the C-terminal fusion of the biotin 228 ligase BirA to L2. BirA will specifically biotinylate the BAP (biotin acceptor peptide) 229 substrate. Upon passage of L2-BirA across limiting membranes in reporter HaCaT-230 GFP-BAP cells, BirA will encounter and biotinylate the substrate GFP-BAP providing an 231 easy readout for translocation. We first confirmed that the HaCaT-GFP-BAP cells were 232 efficiently depleted for GSH upon treatment with BSO (Table 1) and that this led to 233 inhibition of HPV16 infection as observed with parental HaCaT cells ( Fig 5A) . vectors, suggesting a block specific to HPV16. GSH depletion had no effect on binding, Although the precise mechanisms underlying the requirement for GSH remain to 258 be determined, these findings are novel and significant because they represent only the 259 second broad cellular "factor" necessary for this enigmatic process, the first being 
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HaCaT cells ± BSO were plated on coverslips and infected with HPV16 for 2h or 8h 542 prior to fixation and processing for IF as described in Materials & Methods. Total L1 was 543 stained with rabbit anti-L1 polyclonal antibody and anti-rabbit secondary antibody 544 (green). Degraded L1 was stained with mouse L1-7 monoclonal antibody and anti- 
